Seeking Alpha
 

Monsanto Company (MON)

- NYSE
  • Jan. 7, 2013, 5:30 PM
    Notable earnings before Tuesday’s open: MON, RPM
    | Comment!
  • Dec. 4, 2012, 5:07 PM
    Monsanto (MON) will resume collecting royalties for its Roundup Ready soybeans in Brazil while it appeals a court ruling there on intellectual property rights. Brazilian growers say the original patent expired in 2010, ending their obligation to pay MON a technology fee on the seeds; MON says Brazilian law extends the patent to 2014, when it expires in the U.S.
    | Comment!
  • Dec. 3, 2012, 12:18 PM
    Monsanto (MON) declares $0.375/share quarterly dividend, in line with previous. Forward yield 1.64%. For shareholders of record Jan. 04. Payable Jan. 25. Ex-div date Jan. 02. (PR)
    | Comment!
  • Nov. 28, 2012, 5:38 PM
    EU food safety regulators say there is no need to reevaluate the safety of Monsanto's (MON) genetically engineered NK603 corn because a study linking the crop to cancer in rats contained serious defects. The EU's decision comes after the French government said last month it would no longer pursue an immediate ban on EU imports of the corn.
    | 7 Comments
  • Nov. 20, 2012, 3:56 PM
    Monsanto (MON +0.9%) is upgraded to Buy from Hold at Topeka Capital, which remains confident in positive ag fundamentals. The firm believes caution about the diminishing effectiveness of certain biotech traits and perceived uncertainty regarding the impending expiration of MON's RR patent in 2014 are now more benign at least in the near-term.
    | Comment!
  • Nov. 19, 2012, 10:03 AM
    Monsanto (MON +2.7%) opens strong after the Justice Department ends its antitrust probe of the seed industry in general and MON's soybean genetic traits business in particular. MON had been the target of complaints saying it was trying to limit access to older, cheaper products to push a new, more expensive offering.
    | 1 Comment
  • Nov. 18, 2012, 3:39 AM
    The DOJ has ended an antitrust investigation into the U.S. seed industry without filing charges. Justice had requested information from Monsanto (MON) about its business practices regarding to its Roundup Ready soybean, which is designed to withstand the application of the herbicide glyphosate. DuPont (DD) also received a demand for information but doesn't believe the probe was aimed at its behavior.
    | Comment!
  • Nov. 5, 2012, 11:31 AM
    Monsanto (MON +1.3%) is upgraded to Buy with a new $100 target price at Monness Crespi, as continually increasing glyphosate prices are leading to greater EPS upside in 2013. The firm sees MON benefiting from these higher prices, both in its branded Roundup products as well as in its generic glyphosate, and raises estimates to well above consensus.
    | 1 Comment
  • Oct. 23, 2012, 2:05 PM
    The slide in DuPont (DD -9%) shares wipes away all their 2012 gains following the weak Q3 earnings report. But DD says it remains on track to achieve its full-year 2012 productivity targets for both fixed costs and working capital, and it is "taking the necessary steps" to move long-term into higher growth, higher margin businesses such as agriculture, nutrition and biotech. Also: DOW -3.1%, MON -1.8%.
    | 1 Comment
  • Oct. 22, 2012, 5:13 PM
    The French government decides against seeking a ban on EU imports of a type of Monsanto's (MON) genetically modified corn after the country's food safety agency ruled that a study linking the crop to cancers in rats was flawed and inconclusive.
    | 5 Comments
  • Oct. 17, 2012, 12:10 PM
    Monsanto (MON -1.6%) suspends soybean royalty collections in Brazil while it appeals a state court ruling on intellectual property rights siding with a group of growers that a patent on first-generation Roundup Ready soybeans had expired. MON expects appellate courts to decide whether collections can resume over the next several weeks, prior to the start of an actual trial.
    | Comment!
  • Oct. 5, 2012, 5:07 PM
    The Supreme Court agrees to hear an Indiana farmer's appeal that challenges the patent rights of Monsanto's (MON) Roundup Ready seeds. MON, whose genetically modified seeds produce crops resistant to herbicide, has required farmers to use the patented seeds only for a single crop and not save the second-generation seeds from the harvest.
    | 3 Comments
  • Oct. 3, 2012, 8:49 AM
    More on Monsanto's (MON) FQ4 results: In addition to missing its EPS and revenue numbers, MON issues downside guidance for FY 2013, seeing EPS of $4.18-$4.32 vs. $4.37 analyst consensus. For FY 2012, Seeds and Genomics sales were $9.8B, a 14% increase Y/Y; FQ4 sales in the segment were $1.2B, 10% lower Y/Y. MON -3.1% premarket.
    | 1 Comment
  • Oct. 3, 2012, 8:08 AM
    Monsanto (MON): FQ4 EPS of -$0.44 misses by $0.01. Revenue of $2.18B misses by $70M. Shares -3.7% premarket. (PR)
    | Comment!
  • Oct. 3, 2012, 12:05 AM
    Notable earnings before Wednesday’s open: FDO, MON, RPM
    | Comment!
  • Oct. 2, 2012, 5:30 PM
    Notable earnings before Wednesday’s open: FDO, MON, RPM
    | Comment!
Visit Seeking Alpha's
MON vs. ETF Alternatives
Company Description
Monsanto Co is a provider of agricultural products for farmers. The Company offers corn, soybean, cotton, wheat, canola, sorghum and sugar cane seeds. Its segments are Seeds and Genomics and Agricultural Productivity.